These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22521548)

  • 1. Incretins and thiazolidinediones in glucose homeostasis and cancer: role of common polymorphisms.
    Arora S; Mehrotra A; Gulati SC
    Cancer Lett; 2012 Oct; 323(2):128-34. PubMed ID: 22521548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
    Ranganath LR
    J Clin Pathol; 2008 Apr; 61(4):401-9. PubMed ID: 18375745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
    Chaudhuri A; Dandona P
    Diabetes Obes Metab; 2011 Oct; 13(10):869-79. PubMed ID: 21569185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and pioglitazone: Effectively treating insulin resistance.
    Staels B
    Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of GLP-1 for glucose homeostasis. Discovery of incretin].
    Blume H; Wedemeyer RS; Gallwitz B
    Pharm Unserer Zeit; 2010 Mar; 39(2):100-6. PubMed ID: 20196036
    [No Abstract]   [Full Text] [Related]  

  • 8. Pleiotropic effects of thiazolidinediones.
    Rizos CV; Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Expert Opin Pharmacother; 2008 May; 9(7):1087-108. PubMed ID: 18422468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of incretins on blood pressure: a promising therapy for type 2 diabetes mellitus with hypertension.
    Wang B; Ni Y; Zhong J; Sun F
    J Diabetes; 2012 Mar; 4(1):22-9. PubMed ID: 22040104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of thiazolidinediones in the management of type 2 diabetes: focus on ethnic minority populations.
    Umpierrez G; Dagogo-Jack S
    Ethn Dis; 2006; 16(1):51-7. PubMed ID: 16599348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and cancer: a consensus report.
    Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D
    CA Cancer J Clin; 2010; 60(4):207-21. PubMed ID: 20554718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.
    Derosa G; Tinelli C; Maffioli P
    Diabetes Obes Metab; 2009 Dec; 11(12):1091-9. PubMed ID: 19765050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between polymorphisms of TCF7L2 and type 2 diabetes with special reference to incretin action].
    Enya M; Horikawa Y; Takeda J
    Nihon Rinsho; 2011 May; 69(5):930-6. PubMed ID: 21595284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidiabetics which affect the incretin system].
    Kase ET; Birkeland KI
    Tidsskr Nor Laegeforen; 2008 Feb; 128(4):440-2. PubMed ID: 18274578
    [No Abstract]   [Full Text] [Related]  

  • 15. Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes.
    Gad MZ; Ehssan NA; Ghiet MH; Wahman LF
    Pak J Pharm Sci; 2010 Jul; 23(3):305-12. PubMed ID: 20566445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incretin-mimetic drugs, an insulin alternative in type 2 diabetes].
    Fabreegas B
    Soins; 2008 Jun; (726):34-7. PubMed ID: 18697336
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic polymorphisms in diabetes: influence on therapy with oral antidiabetics.
    Glamočlija U; Jevrić-Čaušević A
    Acta Pharm; 2010 Dec; 60(4):387-406. PubMed ID: 21169132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin hormones and beta cell function in chronic pancreatitis.
    Knop FK
    Dan Med Bull; 2010 Jul; 57(7):B4163. PubMed ID: 20591345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incretin strategy in the treatment of type 2 diabetes mellitus--DPPIV].
    Perusicová J
    Vnitr Lek; 2007 Sep; 53(9):1005-9. PubMed ID: 18019673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
    Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI
    N Engl J Med; 1998 Mar; 338(13):867-72. PubMed ID: 9516221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.